Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2010-7-1
pubmed:abstractText
Sleep disorders are observed in Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease; however, the underlying mechanisms are unclear. Reduced hypocretin (orexin) levels are reported in Parkinson's disease and sleep disorders, including narcolepsy; however, its levels in dementia with Lewy bodies and Alzheimer's disease and its relationship with sleep disturbances in these disorders remain undetermined. We examined hypocretin levels in dementia with Lewy bodies and Alzheimer's disease cases and correlated these with sleep habits and clinical characteristics. Although limited hypocretin alterations were observed in Alzheimer's disease, we show reduced neocortical hypocretin immunoreactivity in dementia with Lewy bodies patients correlating with hypersomnolence and alpha-synuclein levels. These results suggest the involvement of hypocretin in sleep disorders in dementia with Lewy bodies.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-10991663, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-12874400, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-12939433, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-14769395, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-15729517, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-15854856, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-16904080, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-16914880, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-17470494, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-17491094, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-1759558, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-19097685, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-19582404, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-19689309, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-19742419, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-19858078, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-20146689, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-8909416, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-8967758, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-9419374, http://linkedlifedata.com/resource/pubmed/commentcorrection/20531237-9491897
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
1473-558X
pubmed:author
pubmed:issnType
Electronic
pubmed:day
4
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
756-60
pubmed:dateRevised
2011-9-26
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Reduced hypocretin (orexin) levels in dementia with Lewy bodies.
pubmed:affiliation
Departments of Neurosciences, University of California, San Diego, La Jolla, California, USA. slessig@ucsd.edu
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural